BrainStorm's Cell Therapy Disappoints In Phase III ALS Study

But Subgroup Analysis Encouraging

 
• By John Davis
  
amyotrophic lateral sclerosis
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category